The store will not work correctly when cookies are disabled.
4-methyl-N-(6-(quinolin-8-yl)pyridazin-3-yl)benzenesulfonamide
ID: ALA4764672
PubChem CID: 149094700
Max Phase: Preclinical
Molecular Formula: C20H16N4O2S
Molecular Weight: 376.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(-c3cccc4cccnc34)nn2)cc1
Standard InChI: InChI=1S/C20H16N4O2S/c1-14-7-9-16(10-8-14)27(25,26)24-19-12-11-18(22-23-19)17-6-2-4-15-5-3-13-21-20(15)17/h2-13H,1H3,(H,23,24)
Standard InChI Key: QTGXPMJSEBIRGK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
41.8625 -5.1714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.4580 -4.4657 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.0490 -5.1688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6294 -4.4780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6283 -5.2975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3363 -5.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0460 -5.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0432 -4.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3346 -4.0691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9222 -5.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2145 -5.2950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5069 -5.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5059 -6.5204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7493 -4.0631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.1647 -4.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8724 -4.4671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5781 -4.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5755 -3.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8612 -2.8328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1585 -3.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2811 -2.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9229 -6.5197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2189 -6.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2209 -7.7390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9262 -8.1439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6309 -7.7313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6254 -6.9210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 23 1 0
22 10 1 0
5 10 1 0
8 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 22 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.44 | Molecular Weight (Monoisotopic): 376.0994 | AlogP: 3.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.84 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.21 | CX Basic pKa: 3.58 | CX LogP: 3.56 | CX LogD: 2.79 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -1.59 |
References
1. Kimura H,Suda H,Kassai M,Endo M,Deai Y,Yahata M,Miyajima M,Isobe Y. (2021) N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors., 33 [PMID:33359168] [10.1016/j.bmcl.2020.127753] |